Jan 10, 2022 / 10:15PM GMT
Matthew Bannon -
All right. Thank you, and welcome back to the 40th Annual JPMorgan Healthcare Conference. My name is Matt Bannon. I'm a healthcare banker here at JPM. I'm really excited to introduce our next presenting company, Exelixis. And on behalf of Exelixis, we have President and CEO, Michael Morrissey. Mike, I'll turn it over to you.
Michael M. Morrissey - Exelixis, Inc. - CEO, President & Director
Fantastic and thanks, Matthew, and thanks to the entire JPMorgan team for the invite and the opportunity to tell you about Exelixis and how we're looking at 2022 and beyond. I was just talking to Chris Senner, our CFO, about doing this live back in 2020, and that seems like a lifetime ago and I'm really hopeful that we'll be doing this live again in 2023.
So -- but here we are, we're virtual. We're in Alameda. And I'll walk you through the deck that we've got and be happy to answer some questions. First slide, the title, I think, to a certain degree, says it all. We are really in the process of moving to become a global multiproduct oncology company. We
Exelixis Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers